Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2016
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic CancerMatthew R Farren, Thomas A Mace, Susan Geyer, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 16, 2015
Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cellsGregory B Lesinski, Patrick K Reville, Thomas A Mace, et al.Cancer Research|March 22, 2013
Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent mannerThomas A Mace, Zeenath Ameen, Amy Collins, et al.Scientific Reports|March 27, 2019
Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell functionThomas A Mace, Michael B Ware, Samantha A King, et al.Journal for Immunotherapy of Cancer|June 23, 2016
Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5Jason W-L Eng, Thomas A Mace, Rohit Sharma, et al.Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.Scientific Reports|May 13, 2017
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivoHannah M Komar, Gregory Serpa, Claire Kerscher, et al.Frontiers in Physiology|June 20, 2022
A Pilot Study to Assess Opportunistic Use of CT-Scan for Osteoporosis Screening in Chronic PancreatitisJulia McNabb-Baltar, Hanisha R Manickavasagan, Darwin L Conwell, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2021
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186Cameron J Herting, Matthew R Farren, Yan Tong, et al.Plos One|August 18, 2012
Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell linesMatthew A Bill, Courtney Nicholas, Thomas A Mace, et al.Pageof 7